VOLITIONRX LTD — Director's Dealing 2016

May 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-04

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-04	Warrant (Right to Buy)	$2.6	D	5000	Disposed	2016-05-10	Common Stock (5000)	Indirect
2016-05-04	Warrant (Right to Buy)	$2.6	A	5000	Acquired	2017-05-10	Common Stock (5000)	Indirect

Footnotes

F1: The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on May 11, 2012 with an expiration date of May 10, 2016. The warrant expiration date was extended one year to May 10, 2017.

F2: The warrant is owned of record by Borlaug Limited, a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the Common Stock issuable to Borlaug Limited upon the exercise of the warrant. Dr. Micallef disclaims beneficial ownership of the Common Stock issuance upon exercise of the warrant, except to the extent of his pecuniary interest therein.